Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mateus Crespo

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Cancer Research|May 20, 2016
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer CellsRoberta Ferraldeschi, Jonathan Welti, Marissa V Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
European Urology|March 8, 2021
CD38 in Advanced Prostate CancersChristina Guo, Mateus Crespo, Bora Gurel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate CancerAntje Neeb, Ines Figueiredo, Bora Gurel, et al.
European Urology|July 13, 2020
Elucidating Durable Responses to Immune Checkpoint InhibitionPasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
Investigational New Drugs|May 15, 2026
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancerKhobe Chandran, Christina Guo, Simon Pacey, et al.
European Urology Oncology|March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate CancerRafael Grochot, Christina Guo, Suzanne Carreira, et al.
Journal of Hematopathology|August 12, 2009
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approachAnke van Rijk, David Mason, Margaret Jones, et al.
Cell Reports|January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate CancerXiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cancer Research|May 20, 2016
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer CellsRoberta Ferraldeschi, Jonathan Welti, Marissa V Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical QualificationGeorge Seed, Wei Yuan, Joaquin Mateo, et al.
European Urology|March 8, 2021
CD38 in Advanced Prostate CancersChristina Guo, Mateus Crespo, Bora Gurel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate CancerAntje Neeb, Ines Figueiredo, Bora Gurel, et al.
European Urology|July 13, 2020
Elucidating Durable Responses to Immune Checkpoint InhibitionPasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
Investigational New Drugs|May 15, 2026
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancerKhobe Chandran, Christina Guo, Simon Pacey, et al.
European Urology Oncology|March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate CancerRafael Grochot, Christina Guo, Suzanne Carreira, et al.
Journal of Hematopathology|August 12, 2009
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approachAnke van Rijk, David Mason, Margaret Jones, et al.
Cell Reports|January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate CancerXiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Pageof 6